Elicio Therapeutics Inc
NASDAQ:ELTX

Watchlist Manager
Elicio Therapeutics Inc Logo
Elicio Therapeutics Inc
NASDAQ:ELTX
Watchlist
Price: 10.6 USD -3.9% Market Closed
Market Cap: 169.6m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ELTX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ELTX Intrinsic Value
Not Available
Base Case Scenario
Compare ELTX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ELTX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Elicio Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Elicio Therapeutics Inc

Current Assets 22.6m
Cash & Short-Term Investments 22.1m
Other Current Assets 510k
Non-Current Assets 6.9m
PP&E 5.6m
Other Non-Current Assets 1.3m
Efficiency

Free Cash Flow Analysis
Elicio Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Elicio Therapeutics Inc

Revenue
0 USD
Operating Expenses
-44.6m USD
Operating Income
-44.6m USD
Other Expenses
-10m USD
Net Income
-54.6m USD
Fundamental Scores

ELTX Profitability Score
Profitability Due Diligence

Elicio Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
25/100
Profitability
Score

Elicio Therapeutics Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ELTX Solvency Score
Solvency Due Diligence

Elicio Therapeutics Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
High D/E
40/100
Solvency
Score

Elicio Therapeutics Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ELTX Price Targets Summary
Elicio Therapeutics Inc

Wall Street analysts forecast ELTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELTX is 12.75 USD with a low forecast of 12.12 USD and a high forecast of 13.65 USD.

Lowest
Price Target
12.12 USD
14% Upside
Average
Price Target
12.75 USD
20% Upside
Highest
Price Target
13.65 USD
29% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Elicio Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ELTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ELTX Insider Trading
Buy and sell transactions by insiders